1. Home
  2. LOOP vs LPCN Comparison

LOOP vs LPCN Comparison

Compare LOOP & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.49

Market Cap

65.7M

Sector

Industrials

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.00

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
LPCN
Founded
2010
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.7M
61.8M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
LOOP
LPCN
Price
$1.49
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
120.3K
390.7K
Earning Date
01-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
46.18
EPS
N/A
N/A
Revenue
$10,889,000.00
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
$174.82
$74.43
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
N/A
52 Week Low
$0.88
$1.81
52 Week High
$2.29
$12.37

Technical Indicators

Market Signals
Indicator
LOOP
LPCN
Relative Strength Index (RSI) 61.27 25.32
Support Level $1.44 N/A
Resistance Level $1.75 $3.40
Average True Range (ATR) 0.10 0.56
MACD 0.01 -0.47
Stochastic Oscillator 73.06 2.54

Price Performance

Historical Comparison
LOOP
LPCN

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: